What is Brevium?
Brevium operates at the intersection of healthcare administration and automated software solutions. The company specializes in patient reactivation, providing a sophisticated platform that identifies and re-engages patients who have fallen out of the care cycle. By integrating directly with existing practice management systems, Brevium enables clinics to streamline scheduling, improve patient compliance, and ultimately drive sustainable revenue growth. Its value proposition is rooted in the ability to turn dormant patient lists into active, recurring revenue streams, a capability that has become increasingly vital for modern medical practices facing rising operational costs and the need for improved patient outcomes.
How much funding has Brevium raised?
Brevium has raised a total of $1.4M across 2 funding rounds:
Debt
$350K
Private Equity
$1M
Debt (2020): $350K with participation from PPP
Private Equity (2025): $1M, investors not publicly disclosed
Key Investors in Brevium
Undisclosed Investor
A private equity firm focused on scaling high-growth healthcare technology companies through strategic capital deployment.
PPP
Public-Private Partnership
What's next for Brevium?
With this major strategic investment, Brevium is well-positioned to scale its enterprise-level operations and expand its footprint across diverse medical specialties. The company is expected to leverage this capital to enhance its proprietary algorithms, further refining the precision of its reactivation tools. As the healthcare industry continues to prioritize patient-centric digital transformation, Brevium's focus on seamless integration and measurable return on investment will likely serve as a catalyst for broader market adoption. Future growth initiatives will likely center on deepening its technological infrastructure and expanding its reach within the competitive landscape of practice management software.
See full Brevium company page
